RXRX
Recursion Pharmaceuticals, Inc.Company with tickers: RXRX
CIK
1601830
CUSIP
75629V104
Shares Outstanding
524,677,865
13F Activity (30d)
193 filings
189 filers
Quarterly earnings calls grouped as a single event — the transcript, the 8-K earnings release, and (where available) the audio and slide deck. Each badge shows which artefacts have landed for that quarter.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| FY2025 Q4 | 2025-12-31 | Recursion Pharmaceuticals, Inc. Q4 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q3 | 2025-09-30 | Recursion Pharmaceuticals, Inc. Q3 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q2 | 2025-06-30 | Recursion Pharmaceuticals, Inc. Q2 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2025 Q1 | 2025-03-31 | Recursion Pharmaceuticals, Inc. Q1 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q4 | 2024-12-31 | Recursion Pharmaceuticals, Inc. Q4 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q2 | 2024-06-30 | Recursion Pharmaceuticals, Inc. Q2 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2024 Q1 | 2024-03-31 | Recursion Pharmaceuticals, Inc. Q1 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K
|
|
| FY2023 Q4 | 2023-12-31 | Recursion Pharmaceuticals, Inc. Q4 FY2023 Earnings Call |
Audio
Transcript
Slides
8-K
|
Showing 1–8 of 8 earnings calls